drugset / Trial / NCT00811564
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
A three-month evaluation comparing the safety and efficacy of a fixed combination of 0.2% brimonidine tartrate/0.5% timolol maleate with that of latanoprost 0.005%, a prostaglandin analogue in glaucoma or ocular hypertension subjects
Timeline
- Start
- 2008-12
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Small molecule | 0.2 % | Other |
| Comparator | Latanoprost | Small molecule | 0.005 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |